Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Jaeger

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2012
Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional studyIvana Pavik, Philippe Jaeger, Lena Ebner, et al.
Kidney International|October 15, 2010
Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphateIvana Pavik, Philippe Jaeger, Andreas D Kistler, et al.
BMC Nephrology|December 6, 2017
Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formersHarald Seeger, Andrea Kaelin, Pietro M Ferraro, et al.
Kidney International|January 10, 2014
Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney diseaseDaniela Spichtig, Hongbo Zhang, Nilufar Mohebbi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 24, 2011
Soluble klotho and autosomal dominant polycystic kidney diseaseIvana Pavik, Philippe Jaeger, Lena Ebner, et al.
Journal of the American Society of Nephrology : JASN|May 15, 2012
Calcium deficiency reduces circulating levels of FGF23María E Rodriguez-Ortiz, Ignacio Lopez, Juan R Muñoz-Castañeda, et al.
The New England Journal of Medicine|March 1, 2002
Intravenous zoledronic acid in postmenopausal women with low bone mineral densityIan R Reid, Jacques P Brown, Peter Burckhardt, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2012
Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional studyIvana Pavik, Philippe Jaeger, Lena Ebner, et al.
Kidney International|October 15, 2010
Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphateIvana Pavik, Philippe Jaeger, Andreas D Kistler, et al.
BMC Nephrology|December 6, 2017
Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formersHarald Seeger, Andrea Kaelin, Pietro M Ferraro, et al.
Kidney International|January 10, 2014
Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney diseaseDaniela Spichtig, Hongbo Zhang, Nilufar Mohebbi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 24, 2011
Soluble klotho and autosomal dominant polycystic kidney diseaseIvana Pavik, Philippe Jaeger, Lena Ebner, et al.
Journal of the American Society of Nephrology : JASN|May 15, 2012
Calcium deficiency reduces circulating levels of FGF23María E Rodriguez-Ortiz, Ignacio Lopez, Juan R Muñoz-Castañeda, et al.
The New England Journal of Medicine|March 1, 2002
Intravenous zoledronic acid in postmenopausal women with low bone mineral densityIan R Reid, Jacques P Brown, Peter Burckhardt, et al.
Pageof 3